Raleigh, NC, United States of America

Joseph Horvatinovich

This inventor holds 1 USPTO granted patent and 4 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Coimmune, Inc.. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joseph Horvatinovich. Retrieved from https://idiyas.com/inventor/joseph-horvatinovich

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Joseph Horvatinovich: Innovator in Dendritic Cell Therapy

Introduction

Joseph Horvatinovich is an accomplished inventor based in Raleigh, NC, who has made significant contributions to the field of immunology. His innovative work in dendritic cell therapy showcases the potential for enhanced treatment outcomes for patients with specific immune system parameters.

Latest Patents

Joseph Horvatinovich holds a patent for "Methods and uses for dendritic cell therapy." This groundbreaking invention outlines methods for evaluating immune system parameters to identify patients likely to benefit from treatment. The patent details procedures for measuring specific treatment indicators, confirming their levels, and administering dendritic cell therapy accordingly.

Career Highlights

Horvatinovich's career highlights include his role at Coimmune, Inc., where he applies his expertise in developing advanced therapeutic methods. His single patent underscores his commitment to innovative healthcare solutions that focus on patient-specific therapies.

Collaborations

Throughout his career, Joseph has collaborated with notable peers such as Charles Nicolette and Mark Debenedette. These partnerships have played a vital role in advancing research and development in immunotherapy.

Conclusion

Joseph Horvatinovich stands out as a significant figure in the realm of biomedical innovations. His patent for dendritic cell therapy promises to reshape treatment protocols for various immunological conditions, demonstrating the impact of dedicated research and collaboration in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…